April 26th 2024
The clinical manifestations of shingles can be divided into 3 phases.
Reducing Barriers Associated With Pneumococcal Vaccine Uptake
1.5 Credits / Immunization, Infectious Diseases
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
The Expanding Landscape of Vaccinations for the Prevention of Pneumococcal Disease: The Role of the Pharmacist as Patient Educator and Vaccinator
1.0 Credit / Pneumococcal Disease
View More
Vaccine-Preventable Diseases: Strategies for Addressing Vaccine Hesitancy and Improving Vaccine Confidence
1.0 Credit / Immunization
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Examining the Evidence for Emerging Vaccines to Prevent RSV-Related Complications in Older Adults
2.0 Credits / Infectious Diseases, Respiratory, Immunization
View More
Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccine Landscape
1.25 Credits / Immunization, Infectious Disease
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacy Technician Credit)
2.0 Credits / Immunization
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacist Credit)
2.0 Credits / Immunization
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Vaccinology: New Vaccine Technology for Autoimmune, Cancers, Infectious Diseases
November 12th 2021Vaccine technologies in development may facilitate a rapid and effective response to new threats and likely will target not only infectious diseases but also allergies, autoimmune conditions, and cancers.
FDA Delays Adolescent COVID-19 Vaccine EUA Announcement for Moderna Vaccine
November 3rd 2021The FDA has notified Moderna that it will need additional time to complete its evaluation of Moderna’s EUA request for the use of the company’s COVID-19 vaccine at the 100-µg dose level in adolescents between 12 and 17 years.
Good Neighbor Pharmacy Reflects on the Success of the Federal Retail Pharmacy Program
September 16th 2021Good Neighbor Pharmacy (GNP) has allocated more than 2 million doses of COVID-19 vaccines to more than 1500 independent pharmacies through its partnership with the Federal Retail Pharmacy Program.